Balefire, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1750924 DALLAS, TX

Position in VRTX

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$237,933

-$103,223 QoQ

Shares Held

479

-37.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#1,338

of 1,735 holders

Holding Since

Mar 2024

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Balefire, LLC holds $1,269,056 across 5 Biotechnology names. VRTX ranks #3 (18.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	7,093	$385,930
2	LGND	Ligand Pharmaceuticals Inc	1,043	$329,681
3	VRTX	Vertex Pharmaceuticals Inc / Ma This page	479	$237,933
4	HALO	Halozyme Therapeutics, Inc.	2,936	$229,800
5	ANNX	Annexon, Inc.	15,011	$85,712

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$237,933	479	-37.3%	Shares	Sole	2026-07-07
2026-03-31	$341,156	764	-4.7%	Shares	Sole	2026-05-07
2025-12-31	$363,594	802	+54.2%	Shares	Sole	2026-01-12
2025-06-30	$231,504	520	+593.3%	Shares	Sole	2025-07-09
2024-06-30	$35,154	75	+47.1%	Shares	Sole	2024-08-01
2024-03-31	$21,318	51	—	Shares	Sole	2024-05-10
No filing history on record for this holder in this stock.